Search
Now showing items 1-1 of 1
Assessing the safety, impact and effectiveness of RTS, S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and …
(BioMed Central, 2022-12)
Following a 30-year development process, RTS,S/AS01E (GSK, Belgium) is the frst malaria vaccine to
reach Phase IV assessments. The World Health Organization-commissioned Malaria Vaccine Implementation Pro‑
gramme (MVIP) ...